Literature DB >> 9229415

Epidemiology and molecular biology of Barrett's adenocarcinoma.

N K Altorki1, S Oliveria, D S Schrump.   

Abstract

In the United States, the incidence of esophageal adenocarcinoma has risen faster than any other malignancy in recent years, and now represents the most common histologic type of esophageal cancer observed in major institutions. The precise etiology of this malignancy, and the epidermiologic variables responsible for its dramatically rising incidence, remains obscure. Elucidation of the molecular biology of malignant transformation in Barrett's esophagus may improve the management of patients with advanced esophageal adenocarcinomas. Furthermore, appreciation of the molecular events associated with esophageal adenocarcinomas. Furthermore, appreciation of the molecular events associated with esophageal adenocarcinogenesis may facilitate early detection of occult carcinomas, and enable therapeutic interventions designed to prevent these otherwise highly lethal neoplasms.

Entities:  

Mesh:

Year:  1997        PMID: 9229415     DOI: 10.1002/(sici)1098-2388(199707/08)13:4<270::aid-ssu9>3.0.co;2-2

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  16 in total

1.  Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats.

Authors:  Harini S Aiyer; Yan Li; Qiao Hong Liu; Nathaniel Reuter; Robert C G Martin
Journal:  Nutrition       Date:  2010-06-11       Impact factor: 4.008

2.  Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study.

Authors:  Seamus J Murphy; Lesley A Anderson; Brian T Johnston; Deirdre A Fitzpatrick; Peter Rg Watson; Pauline Monaghan; Liam J Murray
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus.

Authors:  Junichi Akiyama; Samuel N Marcus; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2012-08-10       Impact factor: 3.199

4.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

5.  Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: a 15-year experience in a single center.

Authors:  Shen-Shong Chang; Ching-Liang Lu; Jing-Yi Chao; Yee Chao; Sang-Hue Yen; Sun-Sang Wang; Full-Young Chang; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.

Authors:  A K Walch; H F Zitzelsberger; J Bruch; G Keller; D Angermeier; M M Aubele; J Mueller; H Stein; H Braselmann; J R Siewert; H Höfler; M Werner
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Outcomes after surgery for esophageal cancer.

Authors:  Thomas A D'Amico
Journal:  Gastrointest Cancer Res       Date:  2007-09

8.  A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents.

Authors:  Tao Zhang; Feng Zhang; Yong Han; Zhongping Gu; Yong'an Zhou; Qingshu Cheng; Yifang Zhu; Chuanshan Zhang; Yunjie Wang
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

9.  Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma.

Authors:  Yan Li; John M Wo; Mukunda B Ray; Whitney Jones; Ruifeng R Su; Susan Ellis; Robert C G Martin
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

10.  MicroRNA expression profiles of esophageal cancer.

Authors:  Andrew Feber; Liqiang Xi; James D Luketich; Arjun Pennathur; Rodney J Landreneau; Maoxin Wu; Scott J Swanson; Tony E Godfrey; Virginia R Litle
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12-26       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.